Investor FAQs

REVA Medical, Inc. ("REVA" or the "Company") is a Delaware corporation. Trading of CHESS Depository Interests ("CDIs") commenced December 23, 2010 on the Australian Securities Exchange ("ASX") under the stock ticker symbol RVA.

To assist shareholders, answers to frequently asked questions are provided below.

Important Notice: The information provided below as answers to frequently asked questions does not take into account your individual investment objectives, financial situation, or needs. The information provided is of a general nature, does not constitute financial advice, and should not be relied upon as the sole basis for any investment decision. Shareholders should contact their financial, legal, and/or tax advisors before deciding to purchase or sell CDIs of REVA

• How do I contact REVA Medical, Inc.?

  Corporate Headquarters:
  
  REVA Medical, Inc.
  5751 Copley Drive
  San Diego, CA 92111
  T: (858) 966-3000
  T: (800) 583-REVA (583-7382)
  F: (858) 966-3099
  E: info@revamedical.com
  
  Investor Relations:
  
  Inquiries from within Australia:
  David Allen / Alan Taylor
  Inteq Limited
  T: +61 2 9231 3322
  
  Inquiries from outside Australia:
  Cheryl Liberatore
  REVA Medical Inc.
  T: (858) 966-3045
  F: (858) 966-3099
  E: cliberatore@revamedical.com

• What stock exchange is REVA listed on?

  REVA is listed on the Australian Securities Exchange ("ASX") under the symbol RVA. Its securities trade in the form of CHESS Depository Interests ("CDIs"). REVA's international ticker symbol is RVA.AX.

• What is a share of common stock?

  A share of common stock represents an ownership interest in a company. Shares of common stock are the U.S. equivalent of ordinary shares in Australia. REVA has been incorporated in the United States and, therefore, has common stock on issue.

• What is a CDI?

  A CHESS Depository Interest, or "CDI," is a type of security that is used on the Australian Securities Exchange to allow foreign companies to be traded. In REVA's case, ten CDIs are equal to one share of common stock. CDIs have all of the privileges and benefits underlying shares of common stock.

• Can I convert my holdings from common stock to CDIs or from CDIs to common stock?

  Yes. One share of common stock is equivalent to ten CDIs.

  Forms for the conversion of common stock to CDIs can be downloaded from Computershare US at this website: https://www-us.computershare.com/Investor/FormsCatalogue.asp?cc=US&lang=en&bhjs=1&fla=1&theme=cpu. Please note that the Computershare webpage lists all forms available from the Computershare US. To convert your holdings from common stock to CDIs, please complete a CDI Issuance USA – AU to be used by a registered shareholder form. Send the completed form to Computershare at one of the following addresses:
  
  Via standard US postal mail:
  Computershare Trust Company, N.A.
  PO Box 43070
  Providence, RI 02940-3070
  U.S.A.
  
  Via overnight/express delivery: Computershare Investor Services, Inc.
  Attn: Global Transaction Unit attn: Karen Correia
  250 Royall St.
  Canton, MA 02021
  U.S.A.
  
  Forms for the conversion of CDIs to common stock can be downloaded from Computershare Australia using REVA's ticker symbol RVA at: https://www-au.computershare.com/Investor/FormsCatalogue.asp. Please note that the Computershare webpage contains all forms offered by Computershare Australia. If you would like to convert your CDIs to common stock, please complete a Removal from AU to DTCC (US) form. Send the completed form to Computershare Investor Services at:
  
  For CDI holders:
  The Registrar
  Computershare Investor Services Pty Limited
  GPO Box 2975
  Melbourne, VIC 3001
  Australia
  
  For further information, please contact Computershare at one of the following telephone numbers:
  
  Regarding CDI positions from within Australia: 1300 855 080
  Regarding CDI positions from outside Australia: +61 3 9415 4000
  Regarding common stock positions from within the United States: (800) 962-4284
  Regarding common stock positions from outside the United States: 1 (781) 575-3120

• What is the ratio of CDIs to common stock?

  Ten CDIs are equivalent to one share of common stock.

• What are REVA's CUSIP and ISIN numbers?

  REVA's CUSIP number is 76133E109 and its ISIN is AU000000RVA3.

• I was a shareholder in MD3, Inc., or, I was a shareholder in REVA Medical, Inc. before the Initial Public Offering. What happened to my shares?

  All existing shareholders of either MD3, Inc. or REVA Medical, Inc. remain shareholders of REVA Medical, Inc. All common stock issued and outstanding remains valid and the current holder retains all rights and privileges. If your shares have been converted to electronic records, you will receive a statement of position from Computershare, the Transfer Agent for REVA's stock. If you hold common stock and retained a paper certificate, that paper certificate is a continuing valid and valuable security. You will need to surrender the certificate to Computershare in the event you ever decide to trade your stock. Contact Computershare for instructions on converting your common stock to electronic format.

• I am located in the United States. How do I find a broker in Australia?

  REVA's shares are traded on the Australian Securities Exchange. Several U.S. investment banks have trading operations in Australia and can provide this service after an account has been opened with them (REVA makes no broker recommendations).

• Does REVA currently have any products for sale?

  At this time, REVA is a development-stage company and does not sell any products.

• What is a bioresorbable scaffold?

  Today, coronary artery disease is often treated by placing a metal stent inside an artery. The metal stent is a permanent implant. It is generally believed that a stent is no longer needed once the artery has healed. A bioresorbable scaffold restores blood flow to the artery and supports the vessel during the critical healing process (estimated at 90 days) in the same manner as a metal stent; however, once the artery has healed, a bioresorbable scaffold gradually resorbs and is cleared from the body, leaving the patient free of a permanent implant.

• Who are the auditors for REVA?

  Ernst & Young LLP
  4370 La Jolla Village Dr. Suite 500
  San Diego, CA 92122

• Who maintains REVA's principal share registry and how do I contact them?

  REVA uses Computershare as their share registry. To contact Computershare:
  
  Regarding CDI positions from within Australia: 1300 855 080
  Regarding CDI positions from outside Australia: +61 3 9415 4000
  Regarding common stock positions from within the United States: (800) 962-4284
  Regarding common stock positions from outside the United States: 1 (781) 575-3120

• How can I obtain a copy of REVA's annual report?

  REVA published its initial annual report in March 2011. The annual report can be downloaded from this website in the Investor Relations section, under SEC Filings and ASX Announcements. Hard copies of the report are available from the Company upon request.

• Can I subscribe to receive alerts about REVA's progress?

  Yes. Any news releases, ASX announcements, SEC filings, and events will be placed on the website and an e-mail notification will be sent out to your preferred e-mail address upon their release. To subscribe to e-mail alerts, please click here.

• How can I unsubscribe from e-mail alerts or change my preferences?

  Click the unsubscribe link at the bottom of any alert. You can also unsubscribe by clicking the link at the bottom of the E-Mail Alerts page and inputting your information on the next page.

• Do you have another question that hasn't been answered?

  Please submit your question using the form below. * Required fields

  Name *
  Email *
  Subject *
  Comments *
  Type in number *
  	This helps REVA Medical, Inc. prevent automated submissions.